These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 33819365
21. Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors. Arbour KC, Naidoo J, Steele KE, Ni A, Moreira AL, Rekhtman N, Robbins PB, Karakunnel J, Rimner A, Huang J, Riely GJ, Hellmann MD. PLoS One; 2017; 12(8):e0182665. PubMed ID: 28771603 [Abstract] [Full Text] [Related]
22. Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma. Wei YF, Chu CY, Chang CC, Lin SH, Su WC, Tseng YL, Lin CC, Yen YT. Lung Cancer; 2018 Nov; 125():35-42. PubMed ID: 30429036 [Abstract] [Full Text] [Related]
23. Impact of PD-L1, transforming growth factor-β expression and tumor-infiltrating CD8+ T cells on clinical outcome of patients with advanced thymic epithelial tumors. Duan J, Liu X, Chen H, Sun Y, Liu Y, Bai H, Wang J. Thorac Cancer; 2018 Nov; 9(11):1341-1353. PubMed ID: 30168897 [Abstract] [Full Text] [Related]
24. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy. Dieci MV, Tsvetkova V, Griguolo G, Miglietta F, Tasca G, Giorgi CA, Cumerlato E, Massa D, Lo Mele M, Orvieto E, Guarneri V, Conte P. Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323 [Abstract] [Full Text] [Related]
26. Comparative clinicopathological and immunohistochemical study of micronodular thymoma and micronodular thymic carcinoma with lymphoid stroma. Liu PP, Su YC, Niu Y, Shi YF, Luo J, Zhong DR. J Clin Pathol; 2021 Sep 07; 75(10):702-5. PubMed ID: 34493600 [Abstract] [Full Text] [Related]
31. Minimally invasive thoracoscopic resection of a micronodular thymoma with lymphoid stroma via a subxiphoid single-incision approach: A case report. Wu Q, Qiao K, Zhang X, Zhou Z. Medicine (Baltimore); 2024 Sep 06; 103(36):e39637. PubMed ID: 39252219 [Abstract] [Full Text] [Related]
33. Expression of PD-1 and PD-L1 in thymic epithelial neoplasms. Weissferdt A, Fujimoto J, Kalhor N, Rodriguez J, Bassett R, Wistuba II, Moran CA. Mod Pathol; 2017 Jun 06; 30(6):826-833. PubMed ID: 28281549 [Abstract] [Full Text] [Related]
34. [Micronodular thymoma with lymphoid stroma(MNT)]. Tahara S, Takami K, Omiya H, Kuriyama K, Kodama Y, Tsujinaka T. Kyobu Geka; 2012 Nov 06; 65(12):1045-8. PubMed ID: 23117355 [Abstract] [Full Text] [Related]
36. The role of CD5 expression in thymic carcinoma: possible mechanism for interaction with CD5+ lymphoid stroma (microenvironment). Hosaka N, Ohe C, Miyasaka C, Nakano Y, Sakaida N, Uemura Y, Saito Y, Ikehara S, Tsubura A, Takahashi H. Histopathology; 2016 Feb 06; 68(3):450-5. PubMed ID: 26018940 [Abstract] [Full Text] [Related]
37. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors. Chan JK, Tsang WY, Seneviratne S, Pau MY. Am J Surg Pathol; 1995 Oct 06; 19(10):1115-23. PubMed ID: 7573670 [Abstract] [Full Text] [Related]